Existing pharmaceutical studies show that Magnolia biondii is effective in treating rhinitis and in reducing cholesterol, given its endogenous, volatile ingredients. The study herein seeks to assess the cosmeceutical activities and anti-inflammatory activities of Magnolia biondii extracts for possible application as cosmetic ingredients. The cosmeceutical and anti-inflammatory activities were investigated using hydroxyl radical scavenging, superoxide dismutase (SOD)-like activity, xanthine oxidase (XO) inhibition, cell viability, nitric oxide (NO) inhibition, and inducible nitric oxide synthase (iNOS) expression by Western blotting. Magnolia biondii extracts were identified to have antioxidant activities in hydroxyl free radical scavenging, SOD-like activity, and XO inhibition. In testing the anti-inflammatory activities of the extracts, NO production was inhibited in a dose-dependent manner.
μg/ml. D: LPS + water extracts 1,000 μg/ml. E: LPS + water extracts 5,000 μg/ml. F: LPS + water extracts 10,000 μg/ml. G: LPS + ethanol extracts 500 μg/ml. H: LPS + ethanol extracts 1,000 μg/ml. I: LPS + ethanol extracts 5,000 μg/ml. J: LPS + ethanol extracts 10,000 μg/ml. 
